» Authors » Feng-Qiang Yu

Feng-Qiang Yu

Explore the profile of Feng-Qiang Yu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 76
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu T, Xu Y, Li J, Yang L, Yu F, Xu Y, et al.
Anal Chem . 2024 Aug; 96(33):13379-13388. PMID: 39105793
Highly sensitive detection of low-frequency EGFR-L858R mutation is particularly important in guiding targeted therapy of nonsmall-cell lung carcinoma (NSCLC). To this end, a ligase chain reaction (LCR)-based electrochemical biosensor (e-LCR)...
2.
Zhuo Y, Huang X, Lin N, Yu F, Chen Y, Guan M, et al.
Biomater Sci . 2023 May; 11(12):4346-4358. PMID: 37140070
Monotherapy of lung cancer shows limited therapeutic effects due to its poorly targeted enrichment and low bioavailability. Using nanomaterials as carriers to form drug delivery systems has become a popular...
3.
Liang M, Yu F, Chen C
Am J Transl Res . 2020 Mar; 12(2):379-388. PMID: 32194890
Immunotherapy using antibodies blocking the programmed cell death 1 (PD-1)/programmed cell death-ligand 1 (PD-L1) pathway has achieved great success in preclinical models and the clinical treatment of esophageal squamous cell...
4.
Shi K, Wang S, Shen B, Yu F, Weng D, Lin J
World J Surg Oncol . 2019 Jan; 17(1):23. PMID: 30691475
Background: Osteosarcoma is a malignant bone tumor with a high potential for lung metastasis, and the prognosis for patients with metastatic disease is very poor. The interaction between fibronectin (FN)...
5.
Yu F, Wang Z, Wang X, Wang S, Li X, Huang Q, et al.
Oncol Lett . 2019 Jan; 17(2):1565-1572. PMID: 30675214
Osteosarcoma (OS) is the most common primary malignant bone tumor. Numerous studies have strongly implicated the ectopic expression of microRNAs (miRNAs/miRs), including miR-885-5p, which is aberrantly expressed in several cancer...
6.
Wang S, Zhong G, Wang X, Yu F, Weng D, Wang X, et al.
Oncol Lett . 2018 Jul; 16(2):2185-2194. PMID: 30008917
The prognosis of patients with metastatic osteosarcoma is poor and has shown no significant improvement in nearly 20 years. The human epidermal growth factor (EGF) receptor (HER) family is frequently...